Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Bristol Myers Squibb Company (BMY) - free report >>
Axis Capital Holdings Limited (AXS) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Bristol Myers Squibb Company (BMY) - free report >>
Axis Capital Holdings Limited (AXS) - free report >>
Image: Bigstock
New Strong Sell Stocks for July 9th
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
AeroVironment, Inc. (AVAV - Free Report) is an operator of portfolio of products and services for government agencies and businesses. The Zacks Consensus Estimate for its current year earnings has been revised 4.4% downward over the last 30 days.
Allegiance Bancshares, Inc. is the bank holding company for Allegiance Bank. The Zacks Consensus Estimate for its current year earnings has been revised 1.1% downward over the last 30 days.
ArcBest Corporation (ARCB - Free Report) is a provider of freight transportation services and integrated logistics solutions. The Zacks Consensus Estimate for its current year earnings has been revised 0.3% downward over the last 30 days.
AXIS Capital Holdings Limited (AXS - Free Report) is a provider of specialty insurance and reinsurance products. The Zacks Consensus Estimate for its current year earnings has been revised 0.2% downward over the last 30 days.
Bristol-Myers Squibb Company (BMY - Free Report) is a manufacturer of biopharmaceutical products. The Zacks Consensus Estimate for its current year earnings has been revised 2.6% downward over the last 30 days.
View the entire Zacks Rank #5 List.